Momenta Continues to Rebuild

Momenta Continues to Rebuild

Source: 
Motley Fool
snippet: 

Momenta Pharmaceuticals' (NASDAQ: MNTA) fourth-quarter earnings were about as rough as the rest of its 2018, a year in which the biotech needed to restructure and cut about half its workforce.